Urine cytokines suggest an inflammatory response in the overactive bladder: A pilot study

International Urology and Nephrology

Volumn 42, Issue 3, 2010, Pages 629-635

  Tyagi, Pradeep ^a   Barclay, Derek ^c   Zamora, Ruben ^c   Yoshimura, Naoki ^b   Peters, Kenneth ^a   Vodovotz, Yoram ^c,d   Chancellor, Michael ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Biomarker; Cytokines; Overactive bladder; Urine

Indexed keywords

BIOLOGICAL MARKER; CD40 LIGAND; CHEMOKINE; CREATININE; CYTOKINE; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GROWTH FACTOR; GROWTH RELATED ONCOGENE ALPHA; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; SOLUBLE INTERLEUKIN 2 RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; INFLAMMATION; MALE; OVERACTIVE BLADDER; PILOT STUDY; URINALYSIS;

ADULT; CD40 LIGAND; CHEMOKINE CCL2; CHEMOKINE CXCL1; CYTOKINES; EPIDERMAL GROWTH FACTOR; HUMANS; INTERLEUKIN-12; INTERLEUKIN-5; MALE; MIDDLE AGED; URINARY BLADDER, OVERACTIVE;

EID: 77956547107     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-009-9647-5     Document Type: Article

References (36)

1. Tyagi S, Thomas CA, Hayashi Y, Chancellor MB (2006) The overactive bladder: epidemiology and morbidity. Urol Clin North Am 33:433-438, vii
2. W Steers 2000 Pathogenesis of the overactive bladder and its attendant risk factors BJU Int 85 Suppl 3 69 11954201 (discussion 70-71)
3. S Segerer PJ Nelson 2005 Chemokines in renal diseases ScientificWorldJournal 5 835 844 1:CAS:528:DC%2BD2MXht1elsrjI 10.1100/tsw.2005.105 16200331
4. GH Tesch 2008 MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy Am J Physiol Renal Physiol 294 F697 F701 1:CAS:528:DC%2BD1cXkvVyktrc%3D 10.1152/ajprenal.00016.2008 18272603
5. GM Ferri A Gigante F Ferri, et al. 2007 Urine chemokines: biomarkers of human lupus nephritis? Eur Rev Med Pharmacol Sci 11 171 178 1:STN:280: DC%2BD2snks1ehuw%3D%3D 17970233
6. SM Bagshaw C Langenberg M Haase L Wan CN May R Bellomo 2007 Urinary biomarkers in septic acute kidney injury Intensive Care Med 33 1285 1296 1:CAS:528:DC%2BD1cXhtV2ltrzK 10.1007/s00134-007-0656-5 17487471 (Pubitemid 47036892)
7. Y Li M Tucci S Narain, et al. 2006 Urinary biomarkers in lupus nephritis Autoimmun Rev 5 383 388 1:CAS:528:DC%2BD28XhtVGiu7rN 10.1016/j.autrev.2005.10. 006 16890891 (Pubitemid 44143030)
8. E Comperat A Reitz A Delcourt F Capron P Denys E Chartier-Kastler 2006 Histologic features in the urinary bladder wall affected from neurogenic overactivity-a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A Eur Urol 50 1058 1064 1:CAS:528: DC%2BD28Xht1erurzJ 10.1016/j.eururo.2006.01.025 16517054 (Pubitemid 44486475)
9. A Apostolidis TS Jacques A Freeman, et al. 2008 Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity Eur Urol 53 1245 1253 1:CAS:528:DC%2BD1cXotlCqtLo%3D 10.1016/j.eururo.2008.02.037 18343564
10. C Nathan 2002 Points of control in inflammation Nature 420 846 852 1:CAS:528:DC%2BD38XpsFygtLY%3D 10.1038/nature01320 12490957 (Pubitemid 36019637)
11. I Innerfield FS Gimble E Blincoe III 1963 Peptidase activity in rat urine following orally given proteases Life Sci 9 671 675 1:STN:280: DyaF2c%2FisFKksw%3D%3D 10.1016/0024-3205(63)90152-8 14068039
12. P Abrams 2005 Urgency: the key to defining the overactive bladder BJU Int 96 Suppl 1 1 3 10.1111/j.1464-410X.2005.05648.x 16086672 (Pubitemid 41224300)
13. A Nixon S Colman L Sabounjian, et al. 2005 A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials J Urol 174 604 607 10.1097/01.ju.0000165461.38088.7b 16006914 (Pubitemid 40981612)
14. E Bettelli M Oukka VK Kuchroo 2007 T(H)-17 cells in the circle of immunity and autoimmunity Nat Immunol 8 345 350 1:CAS:528:DC%2BD2sXjt1Sqs7c%3D 10.1038/ni0407-345 17375096 (Pubitemid 46745409)
15. Loran OB, Pisarev SA, Kleimenova NV, Sukhorukov VS (2007) Allergic inflammation as one of the factors of pathogenesis of overactive urinary bladder. Urologiia 2:37-41
16. K Bouchelouche S Alvarez L Andersen J Nordling T Horn P Bouchelouche 2004 Monocyte chemoattractant protein-1 production by human detrusor smooth muscle cells J Urol 171 462 466 1:CAS:528:DC%2BD3sXps1yqtrY%3D 10.1097/01.ju. 0000090192.36436.d5 14665956 (Pubitemid 37549212)
17. K Bouchelouche S Alvarez T Horn J Nordling P Bouchelouche 2006 Human detrusor smooth muscle cells release interleukin-6, interleukin-8, and RANTES in response to proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha Urology 67 214 219 10.1016/j.urology.2005.07.049 16413378 (Pubitemid 43069300)
18. B Moser C Schumacher V von Tscharner I Clark-Lewis M Baggiolini 1991 Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils J Biol Chem 266 10666 10671 1:CAS:528:DyaK3MXksVOmtro%3D 2037605
19. Smaldone M, Vodovotz Y, Tyagi V et al (2009) Multiplex analysis of urinary cytokine levels in a rat model of cyclophosphamide-induced cystitis. Urology 73(2):421-426
20. A Khadra P Fletcher G Luzzi R Shattock P Hay 2006 Interleukin-8 levels in seminal plasma in chronic prostatitis/chronic pelvic pain syndrome and nonspecific urethritis BJU Int 97 1043 1046 1:CAS:528:DC%2BD28XlsVCgtbY%3D 10.1111/j.1464-410X.2006.06133.x 16643489
21. Torrence AE, Brabb T, Viney JL et al (2008) Serum biomarkers in a mouse model of bacterial-induced inflammatory bowel disease. Inflamm Bowel Dis 14(4):480-490
22. G Otto M Burdick R Strieter G Godaly 2005 Chemokine response to febrile urinary tract infection Kidney Int 68 62 70 1:CAS:528:DC%2BD2MXmt1Cgsbo%3D 10.1111/j.1523-1755.2005.00381.x 15954896 (Pubitemid 43181364)
23. P Ferroni F Guadagni 2008 Soluble CD40L and its role in essential hypertension: diagnostic and therapeutic implications Cardiovasc Hematol Disord Drug Targets 8 194 202 1:CAS:528:DC%2BD1cXhtVCltbbK 10.2174/187152908785849125 18781932
24. D Bastian MV Tamburstuen SP Lyngstadaas O Reikeras 2008 Systemic and local cytokine kinetics after total hip replacement surgery Eur Surg Res 41 334 340 1:STN:280:DC%2BD1cjmslCltg%3D%3D 18815447
25. S Bhangoo D Ren RJ Miller, et al. 2007 Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors Mol Pain 3 38 10.1186/1744-8069-3-38 18076762 (Pubitemid 351234176)
26. M Rossato S Cencig S Gasperini MA Cassatella F Bazzoni 2007 IL-10 modulates cytokine gene transcription by protein synthesis-independent and dependent mechanisms in lipopolysaccharide-treated neutrophils Eur J Immunol 37 3176 3189 1:CAS:528:DC%2BD2sXhtl2qtr3M 10.1002/eji.200737625 17948269 (Pubitemid 350131296)
27. FA White NM Wilson 2008 Chemokines as pain mediators and modulators Curr Opin Anaesthesiol 21 580 585 10.1097/ACO.0b013e32830eb69d 18784482
28. ES Kimball SP Prouty KP Pavlick NH Wallace CR Schneider PJ Hornby 2007 Stimulation of neuronal receptors, neuropeptides and cytokines during experimental oil of mustard colitis Neurogastroenterol Motil 19 390 400 1:CAS:528:DC%2BD2sXhtFyjsr%2FK 10.1111/j.1365-2982.2007.00939.x 17509021 (Pubitemid 46763515)
29. X Qin Y Wan X Wang 2005 CCL2 and CXCL1 trigger calcitonin gene-related peptide release by exciting primary nociceptive neurons J Neurosci Res 82 51 62 1:CAS:528:DC%2BD2MXhtFSrt7bN 10.1002/jnr.20612 16047385 (Pubitemid 41604797)
30. WR Xie H Deng H Li TL Bowen JA Strong JM Zhang 2006 Robust increase of cutaneous sensitivity, cytokine production and sympathetic sprouting in rats with localized inflammatory irritation of the spinal ganglia Neuroscience 142 809 822 1:CAS:528:DC%2BD28XhtVGiu77F 10.1016/j.neuroscience.2006.06.045 16887276 (Pubitemid 44485910)
31. Good DM, Thongboonkerd V, Novak J et al (2007) Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res 6(12):4549-4555
32. JV Candela E Park JM Gerspach, et al. 1998 Evaluation of urinary IL-1alpha and IL-1beta in gravid females and patients with bacterial cystitis and microscopic hematuria Urol Res 26 175 180 1:CAS:528:DyaK1cXktVejtro%3D 10.1007/s002400050043 9694599 (Pubitemid 28305382)
33. T Goto J Morioka H Inamura, et al. 2007 Urinary eosinophil-derived neurotoxin concentrations in patients with atopic dermatitis: a useful clinical marker for disease activity Allergol Int 56 433 438 1:CAS:528: DC%2BD1cXmsFGqsw%3D%3D 10.2332/allergolint.O-07-489 17965582 (Pubitemid 350306396)
34. Zimmerli LU, Schiffer E, Zurbig P et al (2008) Urinary proteomic biomarkers in coronary artery disease. Mol Cell Proteomics 7(2):290-298
35. B Malayappan TJ Garrett M Segal C Leeuwenburgh 2007 Urinary analysis of 8-oxoguanine, 8-oxoguanosine, fapy-guanine and 8-oxo-2′-deoxyguanosine by high-performance liquid chromatography-electrospray tandem mass spectrometry as a measure of oxidative stress J Chromatogr A 1167 54 62 1:CAS:528: DC%2BD2sXhtVClsr3J 10.1016/j.chroma.2007.08.024 17765254 (Pubitemid 47381447)
36. MF Boeniger LK Lowry J Rosenberg 1993 Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review Am Ind Hyg Assoc J 54 615 627 1:CAS:528:DyaK2cXhtlynsQ%3D%3D 8237794